Literature DB >> 34760987

Does neoadjuvant therapy improve survival in pancreatic adenocarcinoma?

Asmita Chopra1, Alessandro Paniccia1.   

Abstract

Entities:  

Year:  2021        PMID: 34760987      PMCID: PMC8527427          DOI: 10.21037/hbsn-21-250

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  5 in total

1.  FOLFIRINOX Versus Gemcitabine-based Therapy for Pancreatic Ductal Adenocarcinoma: Lessons from Patient-derived Cell Lines.

Authors:  Sebastian K S Begg; David J Birnbaum; Jeffrey W Clark; Mari Mino-Kenudson; Ulrich F Wellner; Oliver Schilling; Keith D Lillemoe; Andrew L Warshaw; Carlos FernÁndez-Del Castillo; Andrew S Liss
Journal:  Anticancer Res       Date:  2020-07       Impact factor: 2.480

2.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.

Authors:  John P Neoptolemos; Deborah D Stocken; Helmut Friess; Claudio Bassi; Janet A Dunn; Helen Hickey; Hans Beger; Laureano Fernandez-Cruz; Christos Dervenis; François Lacaine; Massimo Falconi; Paolo Pederzoli; Akos Pap; David Spooner; David J Kerr; Markus W Büchler
Journal:  N Engl J Med       Date:  2004-03-18       Impact factor: 91.245

3.  Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma.

Authors:  Amr I Al Abbas; Mazen Zenati; Caroline J Reiser; Ahmad Hamad; Jae Pil Jung; Amer H Zureikat; Herbert J Zeh; Melissa E Hogg
Journal:  Ann Surg Oncol       Date:  2020-01-02       Impact factor: 5.344

4.  Systemic therapy without radiation may be appropriate as neoadjuvant therapy for localized pancreas cancer.

Authors:  Scott Kizy; Ariella M Altman; Keith M Wirth; Schelomo Marmor; Jane Y C Hui; Todd M Tuttle; Emil Lou; Khalid Amin; Jason W Denbo; Eric H Jensen
Journal:  Hepatobiliary Surg Nutr       Date:  2020-06       Impact factor: 7.293

5.  Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial.

Authors:  Davendra P S Sohal; Mai Duong; Syed A Ahmad; Namita S Gandhi; M Shaalan Beg; Andrea Wang-Gillam; James L Wade; E Gabriela Chiorean; Katherine A Guthrie; Andrew M Lowy; Philip A Philip; Howard S Hochster
Journal:  JAMA Oncol       Date:  2021-03-01       Impact factor: 31.777

  5 in total
  1 in total

1.  The management strategy of pancreatic cancer in the era of systemic therapy-"Surgery First" or "Surgery Last"?

Authors:  Yinmo Yang; Xiaodong Tian
Journal:  Hepatobiliary Surg Nutr       Date:  2022-08       Impact factor: 8.265

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.